Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer

PURPOSE: In 2007, the American Society of Clinical Oncology and the College of American Pathologists had established a human epidermal growth factor receptor 2 (HER2) testing guideline, which was updated in 2013 and subsequently in 2018. We assessed the clinical impact of the recent update by compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Chong, Kang, Su Hwan, Choi, Jung Eun, Bae, Young Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604374/
https://www.ncbi.nlm.nih.gov/pubmed/33154824
http://dx.doi.org/10.4048/jbc.2020.23.e53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604374/
https://www.ncbi.nlm.nih.gov/pubmed/33154824
http://dx.doi.org/10.4048/jbc.2020.23.e53

Ejemplares similares